Willie F Vann
Overview
Explore the profile of Willie F Vann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
349
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kelly M, Janardhanan J, Wagh C, Verma S, Charles R, Leung D, et al.
Vaccine
. 2024 Sep;
42(24):126263.
PMID: 39217775
Immunity protective against shigella infection targets the bacterial O-specific polysaccharide (OSP) component of lipopolysaccharide. A multivalent shigella vaccine would ideally target the most common global Shigella species and serotypes such...
2.
Kelly M, Jeon S, Yun J, Lee B, Park M, Whang Y, et al.
Am J Trop Med Hyg
. 2023 Oct;
109(5):1122-1128.
PMID: 37783453
There is a need for next-generation cholera vaccines that provide high-level and durable protection in young children in cholera-endemic areas. A cholera conjugate vaccine (CCV) is in development to address...
3.
Kelly M, Mandlik A, Charles R, Verma S, Calderwood S, Leung D, et al.
Vaccine
. 2023 Jul;
41(34):4967-4977.
PMID: 37400283
There is a need for vaccines effective against shigella infection in young children in resource-limited areas. Protective immunity against shigella infection targets the O-specific polysaccharide (OSP) component of lipopolysaccharide. Inducing...
4.
Jeon S, Kelly M, Yun J, Lee B, Park M, Whang Y, et al.
Vaccine
. 2021 Oct;
39(47):6936-6946.
PMID: 34716040
There is a need to develop cholera vaccines that are protective in young children under 5 years of age, which induce long-term immunity, and which can be incorporated into the...
5.
Lanz N, Ming S, Thon V, Veeramachineni V, Azurmendi H, Vann W
Biochemistry
. 2021 Jun;
PMID: 34132528
Antiphagocytic capsular polysaccharides are key components of effective vaccines against pathogenic bacteria. groups B and C, as well as serogroups K1 and K92, are coated with polysialic acid capsules. Although...
6.
Azurmendi H, Veeramachineni V, Freese S, Lichaa F, Freedberg D, Vann W
Sci Rep
. 2020 Jul;
10(1):12608.
PMID: 32724125
Capsular polysaccharides are important virulence factors in pathogenic bacteria. Characterizing the structural components and biosynthetic pathways for these polysaccharides is key to our ability to design vaccines and other preventative...
7.
Ou L, Kong W, Chuang G, Ghosh M, Gulla K, ODell S, et al.
Sci Rep
. 2020 Feb;
10(1):3032.
PMID: 32080235
The vaccine elicitation of broadly neutralizing antibodies against HIV-1 is a long-sought goal. We previously reported the amino-terminal eight residues of the HIV-1-fusion peptide (FP8) - when conjugated to the...
8.
Ming S, Caro N, Lanz N, Vionnet J, Vann W
Biochemistry
. 2019 Jan;
58(6):679-686.
PMID: 30602109
Polysialic acids (PSA) are important extracellular virulence factors of the human pathogens Neisseria meningitidis and Escherichia coli. The importance of these polysaccharides in virulence make the polysialyltransferases (PST) targets for...
9.
Ming S, Cottman-Thomas E, Black N, Chen Y, Veeramachineni V, Peterson D, et al.
Glycobiology
. 2017 Dec;
28(2):100-107.
PMID: 29228283
Neisseria meningitidis Group X is an emerging cause of bacterial meningitis in Sub-Saharan Africa. The capsular polysaccharide of Group X is a homopolymer of N-acetylglucosamine α(1-4) phosphate and is a...
10.
Galuska S, Galuska C, Tharmalingam T, Zlatina K, Prem G, Husejnov F, et al.
FEBS J
. 2017 Apr;
284(11):1688-1699.
PMID: 28371406
Neutrophil extracellular traps (NET) are formed against pathogens. However, various diseases are directly linked to this meshwork of DNA. The cytotoxic properties of extracellular histones especially seem to be an...